Atossa Therapeutics
ATOS
ATOS
59 hedge funds and large institutions have $15.8M invested in Atossa Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 24 reducing their positions, and 21 closing their positions.
Holders
59
Holders Change
-14
Holders Change %
-19.18%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
24
Closed
21
Calls
$1.25M
Puts
$971K
Net Calls
+$283K
Net Calls Change
+$420K
Top Buyers
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$913K |
2 |
2
Millennium Management
New York
|
$558K |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$4.75M |
4 |
4
D.E. Shaw & Co
New York
|
$1.47M |
5 |
5
Citadel Advisors
Miami,
Florida
|
$21K |